Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M101,932Revenue $M20,986Net Margin (%)9.9Altman Z-Score2.1
Enterprise Value $M120,769EPS $1.3Operating Margin %19.5Piotroski F-Score5
P/E(ttm)48.8Beneish M-Score-2.1Pre-tax Margin (%)13.0Higher ROA y-yN
Price/Book17.910-y EBITDA Growth Rate %--Quick Ratio1.4Cash flow > EarningsY
Price/Sales4.85-y EBITDA Growth Rate %--Current Ratio1.5Lower Leverage y-yN
Price/Free Cash Flow24.6y-y EBITDA Growth Rate %-38.7ROA % (ttm)6.3Higher Current Ratio y-yN
Dividend Yield %3.1PEG--ROE % (ttm)56.4Less Shares Outstanding y-yN
Payout Ratio %143Shares Outstanding M1,593ROIC % (ttm)23.4Gross Margin Increase y-yY

Gurus Latest Trades with ABBV

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ABBVJoel Greenblatt 2015-06-30 Reduce-0.23%$57.01 - $70.46
($65.18)
$ 61.58-6%Reduce 93.95%33,605
ABBVNWQ Managers 2015-06-30 Reduce-0.19%$57.01 - $70.46
($65.18)
$ 61.58-6%Reduce 13.88%1,583,682
ABBVDavid Dreman 2015-06-30 Add0.11%$57.01 - $70.46
($65.18)
$ 61.58-6%Add 193.03%28,292
ABBVFirst Eagle Investment 2015-06-30 Buy 0.11%$57.01 - $70.46
($65.18)
$ 61.58-6%New holding678,300
ABBVKen Fisher 2015-06-30 Reduce$57.01 - $70.46
($65.18)
$ 61.58-6%Reduce 0.40%1,006,679
ABBVMario Gabelli 2015-06-30 Reduce$57.01 - $70.46
($65.18)
$ 61.58-6%Reduce 1.38%46,562
ABBVDodge & Cox 2015-06-30 Reduce$57.01 - $70.46
($65.18)
$ 61.58-6%Reduce 2.28%34,255
ABBVNWQ Managers 2015-03-31 Add1.27%$55.48 - $67.63
($60.41)
$ 61.582%Add 1815.34%1,839,012
ABBVJoel Greenblatt 2015-03-31 Add0.25%$55.48 - $67.63
($60.41)
$ 61.582%Add 6238.89%555,223
ABBVFirst Eagle Investment 2015-03-31 Sold Out -0.16%$55.48 - $67.63
($60.41)
$ 61.582%Sold Out0
ABBVDavid Dreman 2015-03-31 Buy 0.05%$55.48 - $67.63
($60.41)
$ 61.582%New holding9,655
ABBVKen Fisher 2015-03-31 Add$55.48 - $67.63
($60.41)
$ 61.582%Add 0.96%1,010,756
ABBVMario Gabelli 2015-03-31 Add$55.48 - $67.63
($60.41)
$ 61.582%Add 36.62%47,212
ABBVDodge & Cox 2015-03-31 Reduce$55.48 - $67.63
($60.41)
$ 61.582%Reduce 7.88%35,055
ABBVJohn Paulson 2014-12-31 Sold Out -3.1%$52.9 - $69.71
($63.24)
$ 61.58-3%Sold Out0
ABBVSteve Mandel 2014-12-31 Sold Out -1.2%$52.9 - $69.71
($63.24)
$ 61.58-3%Sold Out0
ABBVGeorge Soros 2014-12-31 Sold Out -0.66%$52.9 - $69.71
($63.24)
$ 61.58-3%Sold Out0
ABBVFirst Eagle Investment 2014-12-31 Buy 0.16%$52.9 - $69.71
($63.09)
$ 61.58-2%New holding1,016,097
ABBVMario Gabelli 2014-12-31 Add0.01%$52.9 - $69.71
($63.09)
$ 61.58-2%Add 232.85%34,557
ABBVJohn Paulson 2014-09-30 Buy 3.1%$52.05 - $59.62
($55.51)
$ 61.5811%New holding13,000,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ABBV is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ABBV: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GONZALEZ RICHARD AChairman of the Board and CEO 2015-07-29Sell40,021$71.24-13.56view
GONZALEZ RICHARD AChairman of the Board and CEO 2015-07-29Sell24,979$71.09-13.38view
HURWICH THOMAS A.VP, Controller 2015-05-19Sell6,200$66-6.7view
GONZALEZ RICHARD AChairman of the Board and CEO 2015-04-28Sell8,281$64.92-5.14view
GONZALEZ RICHARD AChairman of the Board and CEO 2015-04-28Sell64,232$64.84-5.03view
GONZALEZ RICHARD AChairman of the Board and CEO 2015-04-28Sell102,964$64.67-4.78view
RICHMOND TIMOTHY J.SVP, Human Resources 2015-03-02Sell14,388$60.332.07view
Schumacher Laura JEVP, Bus.Dev.,Ext.Aff.&GC 2015-03-02Sell25,000$60.32.12view
HURWICH THOMAS A.VP, Controller 2015-02-27Sell1,185$60.571.67view
SALEKI-GERHARDT AZITASVP, Operations 2015-02-27Sell2,112$60.471.84view

Quarterly/Annual Reports about ABBV:

News about ABBV:

Articles On GuruFocus.com
Baxalta Vs. AbbVie: Biopharma Spin-Off Battle Aug 20 2015 
JNJ – Should It Be In Your Portfolio? Aug 19 2015 
AbbVie: The Riskiest Dividend Aristocrat Aug 18 2015 
First Eagle Investment Buys 19 Stakes in Second Quarter Aug 17 2015 
Green Square Capital's Top Buys in Q2 2015 Aug 13 2015 
First Eagle Fund Of America 2Q Commentary Aug 11 2015 
dividend growth Jul 27 2015 
dividend growth Jul 27 2015 
dividend growth Jul 27 2015 
dividend growth Jul 27 2015 

More From Other Websites
Big Pharma: The Moment of Dread Is Here Sep 03 2015
Novartis launches first U.S. 'biosimilar' drug at 15 pct discount Sep 03 2015
Novartis launches first U.S. 'biosimilar' drug at 15 pct discount Sep 03 2015
Novartis launches first biological copycat drug in US Sep 03 2015
Bristol-Myers/AbbVie Cancer Drug Gets Priority Review Sep 02 2015
9:29 am AbbVie: Par Pharmaceutical begins shipping testosterone gel 1%, the generic version of... Sep 02 2015
The End Of Humira’s Patent - Is AbbVie Prepared? Sep 01 2015
U.S. Food and Drug Administration Accepts for Priority Review the Biologics License Application for... Sep 01 2015
Short Sellers Have Mixed Feelings on Major Pharma Aug 26 2015
Medivation Buying Breast-Cancer Drug From BioMarin Aug 24 2015
AbbVie or Baxalta: Which Is the Better Biopharma Investment Today? Aug 21 2015
Billionaire Larry Robbins Has Healthy Stakes In Health Stocks Aug 20 2015
AbbVie Pays $350 Mil For United Therapeutics Voucher Aug 19 2015
AbbVie buys special review voucher for $350 mln Aug 19 2015
Hedge Funds Are Pouring Money Into These Stocks Aug 19 2015
Biotech Stock Roundup: Kite Addresses Patient Death Concerns, Omeros Soars on Data Aug 19 2015
United Therapeutics Sells Priority-Review Voucher to AbbVie Aug 19 2015
United Therapeutics Corporation Agrees to Sell Priority Review Voucher to AbbVie for $350 Million Aug 19 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK